Indiva Ltd NDVAF

Primary Symbol: V.NDVA.H

Healthcare

Indiva Limited, through its indirect wholly owned subsidiary, Indiva Inc., is a Canada-based producer of cannabis servicing the medical and recreational markets. The Company is engaged in producing and selling cannabis products. It focuses on the production and processing of edible and extract cannabis products as well as packaging of edibles and extracts. Its brands include Pearls by Gron, Bhang Chocolate, Indiva Doppio Sandwich Cookies, Indiva 1432 Chocolate, and No Future Gummies and Vapes, as well as other Indiva branded extracts. Its product category includes edibles, capsules and tablets, and vape. Its edibles include Vanilla Double -Stuffed Chocolate Cookie, and Golden Vanilla Double Stuffed Cookie. The Company sells its cannabis products to consumers in the recreational market in the provinces of Ontario, British Columbia, Alberta, Quebec, Nova Scotia, Saskatchewan, Manitoba, New Brunswick, Prince Edward Island, Newfound.

TSXV:NDVA.H - Post by User

Indiva Ltd > This is the bottom

<< Previous

Bullboard Posts

Next >>

Comment by davgroon Jul 20, 2022 1:24am

129 Views

Post# 34836196

RE:RE:This is the bottom

The facts here are very straightforward. On May 19th, 2022, the company stated in its Q1 2022 financial reporting:

"The company expects Q2 2022 net revenue to be higher sequentially, driven by new product introduction and continued strength in the company's core products."

In a subsequent corporate update issued on June 27th, 2022 the company stated:

"The company also wishes to provide an update to its net revenue guidance provided in its Q1 2022 financial results press release, dated May 19, 2022. Due to delays in deliveries of new products, and delays in provincial delivery appointments, the company now expects net revenue to decline sequentially from Q1 2022. Excluding the impact of these delays, net revenue would have been higher on a sequential basis, as per the company's previous guidance."

Material facts changed with respect to guidance for net revenue for Q2 2022 and the company had an obligation to inform shareholders of this new information. The market has digested this information and the share price has traded accordingly touching a new 52-week low on July 18th.

To suggest that there is more to this than the company fulfilling their fidicuiary responsibility to update shareholders is speculative, irresponsible and dangerous. You can not walk back the comment "...under promise over deliver maybe done deliberately..." as your insinuation is obvious.

nedstar71 wrote:

Duster340 wrote: in my opinion, only goes higher from here. Q2 a month away, is it possible they have a surprise in revenue to the possitve side, under promise over deliver maybe done deliberately, i know they are frustated with the stock price just like bruce campbell is. but what better way to stir up interest in the stock

So you're suggesting that June 27th the company deliberately lied about the lower revenue guidance, in order to surprise to the upside? You can't be serious. I can assure you this company doesn't operate that way and if they did they'd have a heck of a lot more issues than lower revenue to deal with.